Tectonic Therapeutic (TECX) Cash & Equivalents (2017 - 2026)
Tectonic Therapeutic's Cash & Equivalents was $227.1 million in Q2 2026, down 21.0% from $287.38 million a year earlier and down 4.1% from the prior quarter.
Tectonic Therapeutic (TECX) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Tectonic Therapeutic came in at $253.8 million, up 79.7% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $141.24 million in FY2024 (+390.9%), $28.77 million in FY2023 (-68.9%), $92.56 million in FY2022 (-51.2%) and $189.57 million in FY2021 (-27.0%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q4 2024.
- Compared with a year earlier, Cash & Equivalents was higher in four of the last six quarters, with growth averaging 91.8%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2024 (growth of 390.9%); the worst was Q3 2023 (a decline of 94.5%).
- Per Business Quant data, TECX's Cash & Equivalents in the three quarters before Q2 2026 was $236.9 million (Q1 2026), $253.8 million (Q4 2025) and $268.44 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Tectonic Therapeutic | 382.12 Mn | -604.11 Mn | - | 227.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 227.10 Mn |
| Mar 31, 2026 | 236.90 Mn |
| Dec 31, 2025 | 253.80 Mn |
| Sep 30, 2025 | 268.44 Mn |
| Jun 30, 2025 | 287.38 Mn |
| Mar 31, 2025 | 306.25 Mn |
| Dec 31, 2024 | 141.24 Mn |
| Sep 30, 2024 | 159.10 Mn |
| Jun 30, 2024 | 185.12 Mn |
| Mar 31, 2024 | 18.75 Mn |
| Dec 31, 2023 | 28.77 Mn |
| Sep 30, 2023 | 6.33 Mn |
| Jun 30, 2023 | 14.93 Mn |
| Mar 31, 2023 | 72.33 Mn |
| Dec 31, 2022 | 92.56 Mn |
| Sep 30, 2022 | 115.97 Mn |
| Jun 30, 2022 | 132.41 Mn |
| Mar 31, 2022 | 161.66 Mn |
| Dec 31, 2021 | 189.57 Mn |
| Sep 30, 2021 | 201.37 Mn |
Tectonic Therapeutic Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TECX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TECX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TECX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();